[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"psycho-oncological-support\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:psycho-oncological-support":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":5},"100656233","patient-experiences-after-risk-reducing-mastectomy-among-women-carrying-brca12-pathogenic-variants-without-a-diagnosis-of-breast-cancer-100656233",false,"NCT07821593","Patient Experiences After Risk-Reducing Mastectomy Among Women Carrying BRCA1\u002F2 Pathogenic Variants Without a Diagnosis of Breast Cancer","* Female patients aged 18 years or older.\n* Carriers of pathogenic variants associated with hereditary breast and ovarian cancer syndromes (e.g., BRCA1, BRCA2, or other clinically relevant variants).\n* Having previously undergone risk-reducing mastectomy (MRR).\n* Being followed or previously evaluated at the clinical center participating in the study.\n* Ability to understand the study information and complete the survey.\n* Provision of written informed consent for participation in the study.\n* Inability to understand or complete the questionnaire.\n* Refusal or inability to provide informed consent.\n* Incomplete or missing responses to the survey preventing adequate evaluation of the study outcomes.","FEMALE","25 Years","70 Years",{"count":19,"type":20},100,"ESTIMATED","OBSERVATIONAL","This is a descriptive, exploratory cross-sectional, single-center national study. The study asks a sample of women carrying pathogenic variants associated with hereditary breast and ovarian cancer who have undergone risk-reducing mastectomy (MRR) and have signed informed consent to complete an interview developed on the REDCap platform and sent to their personal email address. The aim of the study is to investigate patients' experiences of satisfaction and their correlations with variables included in the survey, based on evidence from the scientific literature.\n\nThese variables include aspects derived from the literature and clinical practice, such as: motivations for choosing to undergo MRR, type of surgical procedure performed, type of reconstruction, presence of residual sensitivity, possible postoperative complications, and the number of surgical procedures required to achieve the final outcome; stability of the couple relationship, partner support, impact of surgery on sexuality, the key question regarding the decision to undergo MRR (question no. 11), and whether the participant would recommend the same pathway to others.\n\nIn addition, the survey includes items derived from the Body Image Scale (Hopwood et al., 2001), translated and validated in Italian (Italian version: Cheli et al., 2016), appropriately adapted to assess the same variable in relation to the MRR procedure (questions no. 2, 4, 6, and 8).\n\nFinally, the last section of the survey includes administration of the 12-Item Short Form Survey (SF-12), a widely used measure of quality of life.\n\nThe questionnaires included in the survey will be appropriately indicated.",[24,25],"Heredo Familial Tumors","Psycho Oncological Support","RECRUITING","2026-09-09",{"date":29,"type":30},"2026-09-16","ACTUAL",{"date":32,"type":30},"2025-05-01",{"date":34,"type":20},"2026-12",{"name":36,"class":37},"Fondazione IRCCS Policlinico San Matteo di Pavia","OTHER"]